Welcome to tranScrip Talks, the podcast for biotech and pharma companies seeking strategic, practical, and expert-led guidance across the entire product lifecycle, from TRANslation to preSCRIPtion. Brought to you by the experts at tranScrip, each episode explores the most pressing challenges and breakthrough opportunities across early and clinical development, market access and commercialisation, regulatory and medical affairs, pharmacovigilance and more.
Expect real case experience, actionable insights and forward-thinking strategies, all designed to help you accelerate and optimise the path from molecule to market.
All content for tranScrip Talks is the property of tranScrip and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to tranScrip Talks, the podcast for biotech and pharma companies seeking strategic, practical, and expert-led guidance across the entire product lifecycle, from TRANslation to preSCRIPtion. Brought to you by the experts at tranScrip, each episode explores the most pressing challenges and breakthrough opportunities across early and clinical development, market access and commercialisation, regulatory and medical affairs, pharmacovigilance and more.
Expect real case experience, actionable insights and forward-thinking strategies, all designed to help you accelerate and optimise the path from molecule to market.
In this episode, host Rob Fox, tranScrip’s Chief Commercial Officer, teams up with Dr Christopher Floyd, Executive Medical Director, Early Development, to explore one of the biggest milestones in drug development: the leap from preclinical to clinical.
They’ll discuss why it’s critical to:
● Weave a compelling translational narrative that carries through to the clinic
● Design adaptive, patient-centred first-in-human studies
● Treat regulators as partners in progress, not barriers to overcome
● Strike the right balance in data collection – clarity over clutter
● Avoid decision paralysis by keeping focus sharp
● Build expert, aligned teams to drive success from day one
In this episode, host Dr Rienk Pypstra, tranScrip’s Chief Medical Officer, joins David Findlay, CEO of Rostra Therapeutics, to lay out the essential blueprint for biotech success.
They’ll explore why it’s vital to:
· Define a laser-focused vision & mission
· Build an early Target Product Profile
· Win investor confidence with a data-driven route to market
· Engage regulators from day one to de-risk development
· Select partners who add real value, not just capacity
Welcome to tranScrip Talks, the podcast for biotech and pharma companies seeking strategic, practical, and expert-led guidance across the entire product lifecycle, from TRANslation to preSCRIPtion. Brought to you by the experts at tranScrip, each episode explores the most pressing challenges and breakthrough opportunities across early and clinical development, market access and commercialisation, regulatory and medical affairs, pharmacovigilance and more.
Expect real case experience, actionable insights and forward-thinking strategies, all designed to help you accelerate and optimise the path from molecule to market.
